Figure 2From: Effects of abciximab on key pattern of human coronary restenosis in vitro: impact of the SI/MPL-ratioMigration. Effects of abciximab (0.0002, 0.002, 0.02, 0.2, 2.0, and 20.0 μg/ml) on migration of HCMSMC (48 h) in comparison to untreated controls. C = controls, bar 100 μm. (p < 0.05 = *; p < 0.01 = **; p < 0.001 = ***; paired Student's t-test).Back to article page